Immunotherapy

 

85 Organization(s)

Adaptimmune

Business Area(s): 
Description: 

Revolutionizing cancer therapy on a global basis by developing TCR therapies with the potential to treat a wide range of cancer types and patients.

Adaptive Biotechnologies

Business Area(s): 
Description: 

T Cell Receptor Analysis

Adheren

Business Area(s): 
Description: 

Cancer immunotherapy

Admune Therapeutics

Business Area(s): 
Description: 

Cancer immunotherapy

Aduro Biotech

Business Area(s): 
Description: 

Aduro’s three proprietary technology platforms (Live, Attenuated Double-Deleted Listeria (LADD), STING Pathway Activators, and B-select monoclonal antibodies) have the potential to transform the ...

Advaxis

Business Area(s): 
Description: 

Advaxis’ Lm Technology uses live, attenuated bioengineered Listeria monocytogenes (Lm) bacteria to stimulate the immune system to view tumor cells as potentially ...

Alpine Immune Sciences

Business Area(s): 
Description: 

The company creates protein-based immunotherapies to treat cancer, autoimmune disorders, and other diseases.

Amgen

Business Area(s): 
Description: 

Biologics.  Amgen makes several therapeutic drugs that target serious disease.  Many are derived from engineered monoclonal antibodies.  Some target immune receptors.

Aminex Therapeutics

Business Area(s): 
Description: 

Aminex Therapeutics, Inc., is a drug development company focused on discovery and development of a unique cancer drug therapy in the general category of cancer immunotherapies known as checkpoint ...

Aptevo Therapeutics

Business Area(s): 
Description: 

Uses modified antibodies to generate immunotherapeutics.

ARMO BioSciences

Business Area(s): 
Description: 

Immunotherapies

AstraZeneca

Business Area(s): 
Description: 

A biopharmaceutical company that focuses on Cardiovascular and Metabolic diseases, Oncology, and Respiratory, Inflammation and Autoimmunity, Infection, Neuroscience and Gastrointestinal diseases, ...

Atara Bio

Business Area(s): 
Description: 

Atara Bio’s programs include T-cell product candidates and molecularly-targeted product candidates.

Aurora Biopharma

Business Area(s): 
Description: 

Immunotherapeutic treatments

AVM Biotechnology

Business Area(s): 
Description: 

Stem Cell Technologies, Fully Human Biologics Manufacturing Cell Lines, Regenerative Medicine, CAR-T Immunotherapy & Cancer Treatment.

BeiGene

Business Area(s): 
Description: 

A biopharmaceutical company dedicated to becoming a leader in the discovery and development of innovative, molecularly targeted and immuno-oncology drugs for the treatment of cancer.

Bellicum Pharmaceuticals

Business Area(s): 
Description: 

Develops next-generation product candidates in some of the most important areas of cellular immunotherapy, including hematopoietic stem cell transplantation (HSCT), CAR T cell therapy, and TCR ...

Biocytics

Business Area(s): 
Description: 

Immunotherapy

BioMmune

Business Area(s): 
Description: 

Immunotherapy

Bioscience Vaccines

Business Area(s): 
Description: 

Adjuvant Technology

Biosortia Pharmaceuticals

Business Area(s): 
Description: 

Adjuvants

bluebird bio

Business Area(s): 
Description: 

The cancer immunotherapy research group is focused on the next generation of T cell engineering and creating a pipeline of T cell product candidates (CAR T cells) to treat a wide variety of liquid ...

Bristol-Meyers Squibb

Business Area(s): 
Description: 

A biopharmaceutical company.  They discover, develop, and deliver medicines to treat serious disease.

Bullet Biotechnology

Business Area(s): 
Description: 

Immunotherapy

Celldex Therapeutics

Business Area(s): 
Description: 

Small Molecules, Biologics, Vaccines, The pipeline is comprised of antibody-based therapies and other protein-based therapeutics that modulate the immune system or directly target tumors. ...

Cellerant Therapeutics

Business Area(s): 
Description: 

Cellerant is developing novel innate and adaptive immunotherapies for oncology and blood-related disorders, including cell-based and antibody therapeutics.

CellSight Technologies

Business Area(s): 
Description: 

CellSight's makes imaging tools to assess the response to immunotherapy..

Checkmate Pharma

Business Area(s): 
Description: 

Develops technology to activate the innate and adaptive arms of the immune system to recognize and ultimately destroy tumor cells.

CisThera

Business Area(s): 
Description: 

CisThera’s mission is to develop innovative therapeutics to treat  cancer, autoimmune diseases, as well as chronic kidney and liver diseases.

Cleveland Biolabs

Business Area(s): 
Description: 

Develops molecules to activate Toll like receptors.  These can be used to stimulate the innate immune system.  

Compugen

Business Area(s): 
Description: 

Compugen, via its wholly-owned subsidiary Compugen USA, Inc., is developing therapeutic antibodies against selected target proteins both for cancer immunotherapy  and antibody-drug conjugate ...

Corvus Pharmaceuticals

Business Area(s): 
Description: 

Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of novel agents that target the immune system to treat patients with cancer. 

Cue BioPharma

Business Area(s): 
Description: 

CytomX Therapeutics

Business Area(s): 
Description: 

Develops cancer immunotherapies, drug conjugates (PDCs), T-cell engaging Probody bispecifics and ProCAR-NK cell therapies based on Protease-Activated Antibodies, 'Probodies'

Dendreon

Business Area(s): 
Description: 

Immunotherapy treatment for prostate cancer.

FivePrime

Business Area(s): 
Description: 

Focused on therapies for cancer and inflammatory diseases

FLX Bio

Business Area(s): 
Description: 

Activating the immune system to eradicate cancer.  Focuses on regulatory T cells.

Forty Seven

Business Area(s): 
Description: 

Committed to the advancement of immuno-oncology through the engagement of new and complementary phagocytic pathways that enhance anti-tumor efficacy and selectivity.

Geneius Biotechnology

Business Area(s): 
Description: 

Immuno-oncology targeting

Gradalis

Business Area(s): 
Description: 

Cancer immunotherapy.  

Immune Design

Business Area(s): 
Description: 

Advancing first-in-class immunotherapy product candidates in oncology, as well as infectious and allergic diseases.

ImmuNext

Business Area(s): 
Description: 

Immunotherapy

Immunotope

Business Area(s): 
Description: 

Immunotherapy for cancer and chronic viral infections

Immusoft

Business Area(s): 
Description: 

Engineers B cells through gene therapy to produce proteins that combat disease.

Incyte

Business Area(s): 
Description: 

Our scientific innovation is based on a unique competency in medicinal chemistry, which is seamlessly integrated into a discovery process that is tailored to individual program needs. We have ...

Inovio Pharmaceuticals

Business Area(s): 
Description: 

Develops DNA vaccines and antigen-targeting immunotherapy to treat cancer and viral infections.

Jounce Therapeutics

Business Area(s): 
Description: 

Cancer Immunotherapies

Juno Therapeutics

Business Area(s): 
Description: 

The company leverages two technologies—CARs and TCRs—to activate a patient’s own T cells so that they attack cancer cells. Through genetic engineering, we insert a gene for a particular CAR or TCR ...

Kite Pharma

Business Area(s): 
Description: 

Kite Pharma is developing engineered autologous T cells that express either a chimeric antigen receptor (CAR) or a T cell receptor (TCR), depending on the type of cancer. The platform has the ...

Lion Biotechnologies

Business Area(s): 
Description: 

Develops tumor-infiltrating T cells designed to overcome the immunosuppressive effects of cancer, while leveraging and enhancing the power of TILs to treat, and potentially cure, all solid tumors ...

MacroGenics

Business Area(s): 
Description: 

A clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, autoimmune disorders and infectious ...

Magenta Therapeutics

Business Area(s): 
Description: 

Magenta’s mission is to revolutionize stem cell transplant as the treatment for immune and blood diseases.

Medicennaæ

Business Area(s): 
Description: 

Immuno-oncology therapies

Merck

Business Area(s): 
Description: 

Small Molecules and therapeutics.

MolecuVax

Business Area(s): 
Description: 

Unsure of business model

MTG Biotherapeutics

Business Area(s): 
Description: 

Immuno-oncology cancer treatment

NantKwest

Business Area(s): 
Description: 

Develops immunotherapeutics that activate natural killer cells.  

NeoImmuneTech

Business Area(s): 
Description: 

Immunotherapy

NewLink Genetics

Business Area(s): 
Description: 

Develops immuno-oncology therapeutics.

Novartis

Business Area(s): 
Description: 

Small Molecules, Vaccines, Biologics